UNLV Experts: Alzheimer’s Drug Development Pipeline [Video]

Alzheimer’s treatment studies offer hope as UNLV expert predicts new potential drugs, biomarkers will yield critical insight for future development.

Dr. Jeffrey Cummings, a leading Alzheimer’s clinician-scientist and research professor in UNLV’s School of Integrated Health Sciences, leads the Alzheimer’s drug development observatory within UNLV’s Department of Brain Health, a robust database of all clinical trials results he began in 2016. It is the only observatory of its kind in the world.

More: https://www.unlv.edu/news/release/alzheimers-drug-development-pipeline-positive-results-new-insight-position-2024